Drawing for NOVOZYMES

USPTO serial 79175795

NOVOZYMES

Reviewed by CopyMark Law Group

Reg. 5102405Status 708Renewal
Filing date
Status date
Registration date
Dec 20, 2016
Examiner
EISNACH, MICHAEL PATRICK
Law office

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Need help with NOVOZYMES?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $548*

Plus Government fees of $1,300

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Vincent O. Wagner

Vincent O. Wagner Woodard, Emhardt, Henry, Reeves & Wagner LLP111 Monument Circle, Suite 3700Indianapolis, IN 46204-5137UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Chemicals used in industryACTIVE
005[ Pharmaceutical and veterinary preparations for cancer treatment and enzyme replacement therapy ]SECTION 71 - CANCELLED
041Educational services, namely, conducting classes, seminars, conferences and workshops in the fields of biochemistry and scientific research within biotechnologyACTIVE
042[ Chemical analysis; chemical and scientific research for others ]SECTION 71 - CANCELLED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 20, 2025REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
May 1, 2025RNWLINTERNATIONAL REGISTRATION RENEWED
Feb 20, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED
Feb 14, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED
Apr 15, 2024INNPPARTIAL INVALIDATION PROCESSED BY THE IB
Mar 20, 2024INPSPARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Mar 20, 2024INPCINVALIDATION PROCESSED
Mar 12, 2024INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Jul 12, 2023NA75NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Jul 12, 2023C75PREGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
Jul 4, 2023APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL
Dec 15, 2022ES75TEAS SECTION 71 & 15 RECEIVED
Dec 20, 2021REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Mar 14, 2019NREPNEW REPRESENTATIVE AT IB RECEIVED
Jan 24, 2019NREPNEW REPRESENTATIVE AT IB RECEIVED
Apr 8, 2017FINOFINAL DECISION TRANSACTION PROCESSED BY IB
Mar 24, 2017OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Mar 21, 2017FICSFINAL DISPOSITION NOTICE SENT TO IB
Mar 21, 2017FIMPFINAL DISPOSITION PROCESSED
Mar 20, 2017FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 20, 2016R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 4, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 4, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 14, 2016OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 14, 2016OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Sep 14, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 26, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Aug 26, 2016XAECEXAMINER'S AMENDMENT ENTERED
Aug 26, 2016GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 26, 2016GNEAEXAMINERS AMENDMENT E-MAILED
Aug 26, 2016CNEAEXAMINERS AMENDMENT -WRITTEN
Aug 25, 2016XAECEXAMINER'S AMENDMENT ENTERED
Aug 25, 2016GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 25, 2016GNEAEXAMINERS AMENDMENT E-MAILED
Aug 25, 2016CNEAEXAMINERS AMENDMENT -WRITTEN
Aug 24, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Aug 23, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 23, 2016TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 29, 2016GEANNOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Apr 29, 2016GEAPEXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Apr 29, 2016EPENCOMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
Apr 29, 2016CPEAEXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Apr 28, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Apr 27, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 27, 2016TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 26, 2016NREPNEW REPRESENTATIVE AT IB RECEIVED
Dec 4, 2015RFNTREFUSAL PROCESSED BY IB
Nov 17, 2015RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 17, 2015RFRRREFUSAL PROCESSED BY MPU
Nov 17, 2015MAFRAPPLICATION FILING RECEIPT MAILED
Nov 14, 2015RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 13, 2015CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 12, 2015DOCKASSIGNED TO EXAMINER
Nov 12, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 7, 2015REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance